CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Scorpius Holdings Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Scorpius Holdings Inc
627 DAVIS DRIVE, SUITE 400
Phone: (919) 240-7133p:919 240-7133 MORRISVILLE, NC  27560  United States Ticker: HTBXHTBX
Business Summary
Scorpius Holdings, Inc., formerly NightHawk Biosciences, Inc., is an integrated contract development and manufacturing company. The Company is focused on advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas. Its analytical services include development of a comprehensive range of analytical test methods to characterize complex biologics, including cell therapy-based products, protein therapeutics, vaccines and advanced therapies. Its Clinical Biomanufacturing includes cGMP Mammalian Cell Culture, and cGMP Microbial Fermentation. Its San Antonio facility is focused on the commercial-scale manufacturing of biodefense-focused molecules and biologics therapeutics. Its biomanufacturing services focus on accelerating product development timelines from pre-clinical evaluation to first-in-human studies.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2022YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer Jeffrey A.Wolf 60 1/1/2008 1/1/2008
Chief Financial Officer, Controller, Secretary William L.Ostrander 55 1/4/2021 9/25/2019
Lead Independent Director John K.Prendergast 69 4/1/2016 4/1/2016
Independent Director John P.Monahan 76 11/1/2009 11/1/2009
Independent Director Edward B.Smith 48 11/1/2010 11/1/2010

Subsidiaries
Business Name Address City State/Province Country
PELICAN THERAPEUTICS INC 8122 DATAPOINT DR, STE 445 SAN ANTONIO TX

Business Names
Business Name
Abacus Biotech, Inc.
Blackhawk Bio, Inc.
Heat Biologics Australia Pty LTD
11 additional Business Names available in full report.

General Information
Number of Employees: 77 (As of 12/31/2022)
Outstanding Shares: 36,031,964 (As of 3/7/2024)
Shareholders: 28
Stock Exchange: ASE
Federal Tax Id: 262844103
Fax Number: (302) 636-5454


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, April 15, 2024